- ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.
Canaccord is bullish on Edwards Lifescience stock.
Here are Thursday's top research calls, including downgrades for CVS, Edwards Lifesciences and Qorvo, and an upgrade for Tesoro.
However, more consolidation may be needed before the uptrend resumes.